Sapiens International (SPNS) has had the highest return since January 22, 2022 by a mid-cap US stock, returning 50,762.8%.
| ASSET | % RETURN |
|---|---|
Sapiens International (SPNS) | 50,762.85% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 3,880% |
Sezzle (SEZL) | 1,907.15% |
Bel Fuse B (BELFB) | 1,437.81% |
Powell Industries (POWL) | 1,389.98% |
Rhythm Pharmaceuticals (RYTM) | 1,343.04% |
ADMA Biologics (ADMA) | 1,263.77% |
Cidara Therapeutics (CDTX) | 1,217.74% |
Belite Bio Inc ADR (BLTE) | 1,213.6% |
Modine Manufacturing (MOD) | 1,181.37% |
Sterling Construction (STRL) | 1,100.92% |
Innodata (INOD) | 1,043.39% |
Bel Fuse A (BELFA) | 998.52% |
Abivax SA American Depositary Shares (ABVX) | 990.34% |
Applied Opt (AAOI) | 909.42% |
Celcuity LLC (CELC) | 902.02% |
Argan (AGX) | 879.66% |
TransMedics (TMDX) | 866.69% |
Banco Macro SA B ADR (BMA) | 843.61% |
CECO Environmental (CECO) | 814.13% |
Nuvalent (NUVL) | 792.4% |
Viking Therapeutics (VKTX) | 783.73% |
Applied Digital (APLD) | 744.67% |
BBVA Banco Frances SA ADR (BBAR) | 736.6% |
Centrus Energy (LEU) | 722.85% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
